Paul J. Schmitt serves as Executive at TETRALOGIC PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Paul J. Schmitt has executed 10 insider transactions totaling $3.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 2, 2015 involved purchasing 6,500 shares valued at $15.2K.
Paul J. Schmitt currently holds 20,000 shares of TETRALOGIC PHARMACEUTICALS CORP (TLOG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul J. Schmitt has been a net buyer of TLOG stock. They have purchased $3.2M and sold $0 worth of shares.
Paul J. Schmitt's most recent insider trade was on Jul 2, 2015, when they purchased 6,500 shares at $2.34 per share.
Get notified when new Form 4 filings are submitted
| $2.33 |
| Discretionary |
| Nov 10, 2014 | TLOG | $41.4K | Purchase | 10,000 | $4.14 | Discretionary |
| Nov 10, 2014 | TLOG | $40.6K | Purchase | 10,000 | $4.06 | Discretionary |
| Dec 17, 2013 | TLOG | $3.1M | Purchase | 445,179 | $7.00 | Discretionary |
| Dec 17, 2013 | TLOG | $0 | Conversion | 261,437 | $N/A | Discretionary |
| Dec 17, 2013 | TLOG | $0 | Conversion | 179,738 | $N/A | Discretionary |
| Dec 17, 2013 | TLOG | $1.4M | Conversion | 193,863 | $7.00 | Discretionary |
| Dec 17, 2013 | TLOG | $34.0K | Exercise | 5,305 | $6.40 | Discretionary |
| Dec 17, 2013 | TLOG | $0 | Conversion | 427,440 | $N/A | Discretionary |